Inorganic arsenic exposure via drinking water has been associated with cancer and serious injury in various internal organs, as well as with peripheral neuropathy and diverse effects in the nervous system. Alterations in memory and attention processes have been reported in exposed children, whereas adults acutely exposed to high amounts of inorganic arsenic showed impairments in learning, memory, and concentration. Glutathione (GSH) is extensively involved in the metabolism of inorganic arsenic and both arsenite and its methylated metabolites have been shown to be potent inhibitors of glutathione reductase (GR) in vitro. Brain would be more susceptible to GR inhibition due to the decreased activities of superoxide dismutase (SOD) and catalase reported in this tissue. To investigate if GR inhibition could be documented in vivo, we determined the activity and levels of GR in brain as well as in liver, the main organ for arsenic metabolism in mice exposed to 2.5, 5 or 10 mg/kg/day of sodium arsenite during 9 days. Different from what has been observed in vitro, significant inhibition of the expression and activity of GR was observed only at the highest concentration used (10 mg/kg/day) in both organs. Although the disposition of arsenicals was higher in liver, significant amounts of inorganic and methylated arsenic forms were determined in the brain of exposed animals. The formation of monomethylarsenic (MMA) and dimethylarsenic (DMA) metabolites in the brain was confirmed incubating brain slices for 24, 48 and 72 h with sodium arsenite.
INTRODUCTION
Inorganic arsenic exposure via drinking water has been associated with cancer and serious injury in various internal organs, as well as with peripheral neuropathy and diverse effects in the circulatory and nervous system. Acute intoxication that produces initial gastrointestinal or cardiovascular symptoms can be followed by the delayed onset of central or peripheral nervous-system involvement. During subacute or chronic exposure, inorganic arsenic can occasionally result in subclinical or overt peripheral neuropathy (Yip et al., 2002) . In children exposed to inorganic arsenic during their whole-life, hearing impairment (Bencko and Symon, 1977) and lower scores in verbal intelligence quotient (IQ) have been reported (Calderon et al., 2001; Wasserman et al., 2004 ) . While alterations in memory and attention processes have been reported in adolescents exposed to high levels of inorganic arsenic in well water (Tsai et al., 2003) , adults acutely exposed showed impairments in learning, memory, and concentration (Bolla-Wilson and Bleecker, 1987; Franzblau and Lilis, 1989; Morton and Caron, 1989) .
Similarly, inorganic arsenic exposure has been related to behavioral alterations in rodents, such as disruption in operant learning (Nagaraja and Desiraju, 1994) , alterations in locomotor activity (Chattopadhyay et al., 2002a; Chattopadhyay et al., 2002b; Itoh et al., 1990; Pryor et al., 1983; Rodriguez et al., 2001; , and increases in errors in the delayed alternation task tested in the T maze . Some of these alterations could be related to changes in cholinergic, monoaminergic, GABAergic and glutamatergic systems in several brain regions such as striatum, midbrain, hypothalamus, and hippocampus of rodents exposed to arsenicals (Delgado et al., 2000; Kannan et al., 2001; Mejia et al., 1997; Desiraju, 1993, 1994; Rodriguez et al., 2001; Tripathi et al., 1997; Valkonen et al., 1983) . In humans and in many mammalian species exposed to inorganic arsenic, at least 4 metabolites that can exert toxic effects have been identify in tissues and fluids. They originate in a metabolic process that is carried out in two processes: a) the reduction of the pentavalent species to trivalency in the presence of glutathione (GSH) or thioredoxin and b) the oxidative methylations where inorganic arsenic is converted to mono and dimethyl arsenic forms (MMA, DMA, respectively). Thus, both pentavalent and trivalent methylarsenic forms are intermediates or products of this pathway Thomas et al. 2004 ).
Few studies have attempted to unravel the mechanism of toxicity of inorganic arsenic exposure in the central nervous system. In vitro studies demonstrated that As exposure caused apoptosis in cortical and cerebellar neurons, while dimethylarsinic acid exposure induced apoptosis in cerebellar neurons only. In both types of cell cultures, apoptosis was induced by caspase activation Xia, 2000, 2001 ). An in vivo study, reported the formation of hydroxyl radicals in the rat striatum, induced by direct infusion of sodium arsenite via a microdialysis probe (García-Chavez et al., 2003) .
However, there are no previous in vivo studies relating the adverse effects of arsenical exposure to the presence of methylated arsenic species in brain, which could be in to some extent responsible for the neurotoxic alterations reported.
The tripeptide GSH (L-γ-glutamyl-cysteinyl-glycine) is the most important intracellular nonprotein thiol in mammalian cells, it is found at concentrations of 1-3 mM in human and monkey brain cells (Slivka et al., 1987) . GSH possess reducing and nucleophilic properties and it can exist in either a reduced (GSH) or oxidized (GSSG) form.
Glutathione reductase (GR, EC 1.6.4.2) is an ubiquitous flavoenzyme, that catalyzes the at Pennsylvania State University on February 23, 2013 http://toxsci.oxfordjournals.org/ Downloaded from NAD(P)H-dependent reduction of GSSG to GSH. This enzyme maintains adequate levels of the cellular GSH pool, which is critical not only to maintain the cellular redox status by keeping sulfhydryl groups of cytosolic proteins in the reduced form (Dringen et al., 2000) but also because numerous toxic o potentially toxic compounds, including some metals, are either taken up or removed from the cells by GSH-mediated pathways (Chouchane and Snow, 2001) . In comparison to other organs, brain is more susceptible to oxidative damage due to the high oxygen utilization (20% of oxygen consumed by the body), high iron content, presence of unsaturated fatty acids, and decreased activities of detoxifying enzymes such as superoxide dismutase (SOD), catalase and GR compared with kidney and liver (Bharath et al., 2002; Dringen et al., 2000) . GSH serves as an antioxidant, reacting with free radicals and organic peroxides, it is also a substrate of the glutathione peroxidase (Maher and Schubert, 2000) and a coenzyme of enzymes such as glutathione-S-transferase, thioltransferases among others (Arrigo, 1999 . Both arsenite and its methylated metabolites have been shown to be potent inhibitors of GR in vitro (Styblo et al., 1995 (Styblo et al., , 1997 Chouchane and Snow, 2001) , thus exposure to arsenicals would compromise the anti-oxidant mechanisms by consuming GSH and inhibiting the enzyme responsible for its recycling in brain, an organ highly susceptible to oxidative damage. To investigate this hypothesis we exposed mice to 2.5, 5 or 10 mg/kg/day of sodium arsenite for 9 days and determined the activity and levels of GR, as well as the 6 formation methylated arsenic metabolites in brain. Several studies have demonstrated that compared with other organs such as lung and kidney, liver is the primary arsenic methylating organ (Hughes et al., 2003; Kitchin et al., 1999) and therefore could also be affected by GR inhibition. Thus, we performed similar determinations in liver of GR levels and activity, measuring also the disposition of arsenicals which served as a reference for the metabolic activity observed in brain. University of Mexico (UNAM) were acclimated during one week to the vivarium conditions. Subsequently, they received 0, 2.5, 5 or 10 mg of sodium arsenite per kg of body weight per day by intragastric route for a total of 9 days. Sodium arsenite (SigmaAldrich, St Louis, MO, USA) solutions were prepared daily and dissolved in deionized water. The control group received deionized water as treatment. Animals had free access to water and food before and during arsenite exposure. Body weight was recorded daily during exposure.
One day after the last dose of inorganic arsenic, mice were sacrificed by cervical dislocation, followed by decapitation. Brain and liver were extracted and washed in icecold isotonic saline solution to remove debris and blood. For immunoblotting determination tissues were homogenized in ice-cold 0.1 M phosphate saline buffer (PBS) pH 7.4, aliquoted in the presence of a proteinase inhibitor cocktail (Sigma-Aldrich) and frozen by immersion in liquid nitrogen. For inorganic arsenic and its methylated metabolites determination tissue was frozen at -80 °C until processing.
Organotypic culture
The procedure used was adapted from Stoppini et al., (1991) . Briefly, after cervical dislocation, adult mice were plunged into a 70% alcohol solution, decapitated, and the brain was rapidly removed. The brain was placed in a vibratome chamber filled with sterile artificial cerebro-spinal fluid (ACSF; 126 mM NaCl; 3 mM KCl; 1 mM MgCl2; 26 mM NaHCO3; 2 mM CaCl2; 10 mM glucose; ascorbic acid 200 µM and thiourea 200 µM; 8 oxygenated at least 1 hour before used). Eight 400 µm longitudinal slices were obtained from each brain and stabilized for 1 hour in ACSF before culturing. Two slices were then placed on pre-wet membranes (30-mm diameter; 0.4um pores; Millicell-CM, Millipore, USA) in 6 well cluster plates containing 1.1 ml of culture media (50% DMEM+Hepes;
25% horse serum and 25% Hank´s solution from GIBCO (Invitrogen, CA, USA); 6.5 mg/ml glucose final concentration (Sigma-Aldrich); penicillin and streptomycin (GIBCO); pH 7.2. Sodium arsenite was dissolved in the culture medium to obtain a non-cytotoxic final concentration of 0.1 µM. Petri dishes were placed in an incubator at 36°C with a 5% CO2-enriched atmosphere for 24, 48 and 72 hours. Non-treated slices were used as controls. At the end of the experiment, the tissue and culture medium were pooled and assessed for methylated forms of arsenic as described below.
Determination of methylated arsenic species
Liver and brain homogenates and culture media were used to measure the levels of arsenic species by hydride generation-atomic absorption spectroscopy after column chromatographic separation of inorganic arsenic and its metabolites: monomethylarsenic (MMA), dimethylarsenic (DMA) and trimethylasenic (TMAO) as described by Hughes et al., (2003) .
Glutathione reductase activity assay
To measure GR activity, homogenates were thawed at room temperature and centrifuged at 700 x g for 10 min. 
Ethics
The experiments reported in this manuscript were carried out following the guidelines stated in "Principles of Laboratory Animal Care" (NIH publication #85-23, revised 1985) and the "Norma Oficial Mexicana de la Secretaría de Agricultura, Ganadería, Desarrollo Rural, Pesca y Alimentación" (SAGARPA) titled "Especificaciones técnicas para la producción, cuidado y uso de los animales de laboratorio" (Clave NOM-062-ZOO-
RESULTS
There were no gross changes on general appearance among groups exposed to 2.5, 5
or 10 mg/kg/day of sodium arsenite and the control group. Similarly, no differences in body weight were observed among control and treated animals (data not shown). Arsenic species were determined in brain homogenates from 5 animals per dose [F,F(3,19) Figures 1A and 1B) . Total arsenic (TAs) concentration in tissue samples reported in this paper is the sum of the concentrations of inorganic arsenic (As), MMA, DMA and TMAO. TAs increased linearly with dose in both brain, and liver ( Figure 2A ).
Control mice showed low levels of arsenic, due to the presence of small amounts of As (0.087-0.097 µg/g of inorganic arsenic and no traces of MMA and DMA) in the Harland 7004 Diet (Harlan, Indiana, USA).
Methylated arsenic species in brain and liver
The distribution of arsenicals was tissue specific. In brain, the concentration of DMA increased linearly with dose ( Figure 1A) . Brains from the group exposed to 10 mg arsenite distinctively showed the highest concentration of DMA. A significant accumulation of MMA was also observed ( Figure 1A ), although it was not as evidently related with dose as the dimethylated species. While inorganic arsenic increased linearly with dose in liver, a different pattern was observed in brain since the amount of inorganic arsenic decreased linearly with dose ( Figure 2B ). In addition TMAO was only detected in liver from mice treated with the highest dose of arsenite, but it was not present in brain ( Figure 1A ).
To confirm that methylation of arsenic was occurring in brain, brain slices were Some reports suggest that inorganic arsenic is able to cross the blood-brain barrier (Vahter and Marafante, 1985; Klaassen, 1996; Rodriguez et al., 2001 ). There is not
information available yet, about arsenical species distribution in brain after acute or sustained arsenical exposure. The results of the present study corroborate the entrance of As in brain and demonstrate the presence of methylated metabolites MMA and DMA in this organ. Also, the proportion of methylated metabolites increased with dose, and this was clearly evident in the DMA species. Thus, at the highest dose of arsenite administered (10 mg/kg/day), the main arsenic methylated species found in brain was DMA ( Figure 1A ).
Total As concentration in liver was higher than in brain, being DMA an exception for brain, since the group exposed to 10 mg/kg/day of arsenite, showed in this organ three times the amount of DMA determined in liver. Selective accumulation of DMA in other organs such as lung and bladder have been also observed in mice in a repeated dose experiment with sodium arsenate (Hughes et al., 2003) . While inorganic arsenic increased linearly with dose in liver, an opposite pattern was observed in brain (Figure 2 ), a similar dose response effect was observed in rat brain (Rodríguez et al., 2001) suggesting that transport of inorganic arsenic to the brain is probably limited or impaired by the bloodbrain barrier. The presence of MMA and DMA in brain could be the result of blood distribution and/or brain methylation. The formation of MMA and DMA in brain slices showed that brain is capable of methylation of inorganic arsenic. At this respect, recent studies reported that brain tissue expresses arsenic methyltransferase (Waters et al., 2003) , also enzymatic activity of MMA V reductase was reported to be higher in brain than bladder, 14 spleen or liver of male golden Syrian hamsters (Sampayo-Reyes et al., 2000) . In human cell lines levels of arsenic methyltransferase mRNA are correlated with the capacity to convert arsenite into methylated metabolites Styblo et al., 2000) .
The presence of small amounts of TMAO in liver, the major site of arsenic methylation (Sakurai et al., 2004) , suggests that DMA was being methylated to TMAO in this tissue, while this was not apparently possible for brain DMA, which therefore is accumulated. The smaller proportion of MMA present in both tissues, in all arsenite exposed groups suggested that the methylation rate is higher for the first and second methylation steps while the third one might require certain accumulation of DMA or inorganic arsenic to occur. Trivalent methylated arsenicals are considered more cytotoxic than either pentavalent or trivalent inorganic arsenic , although the methodology employed here to determine methylated metabolites can not ascertain if they are in their trivalent or pentavalent form, trivalent MMA and DMA have been found in humans chronically exposed to arsenic in drinking water (Del Razo et al., 2001) . It has been proposed that methylathed arsenicals are in trivalent state when they are protein bound due to its high affinity for sulfhydryl groups (Del Razo et al., 2001 , Lin et al. 1999 . Thus, it could be assumed that methylated trivalent species can be found in liver and brain where they might inhibit important antioxidants enzymes such as GR and GPx among others. The interaction of As with GSH and related enzymes seems to be a very important factor for the mechanism of arsenical toxicity. GR is an integral component of the antioxidant defense mechanisms and its inhibition by arsenicals, especially by trivalent methylated forms has been documented in vitro in short term treatment studies Thomas, 1995, Styblo et al. 1997; Chouchane and Snow, 2001 ). Our results showed that a significant inhibition of GR in liver and brain occurred in vivo only when the animals received the highest dose of arsenite (10 mg/kg/day), suggesting that in organisms such as mice, the decrease in antioxidant defense mechanisms by repeated ingestion of arsenite, might occur only at very high doses (over 10 mg/kg/day). We find this observation physiologically important as compared with the in vitro observations since in vivo GR inhibition seems to require high doses of arsenite, at least in the experimental approach described here. Regarding the toxicity of methylated pentavalent species, DMA V is toxic in vitro and in vivo, genotoxic in vitro, and tumor promoter or carcinogen in rodents, while MMA V is slightly toxic in cell cultures it can become weakly toxic when GSH is depleted by the glutathione syntethase inhibitor buthionine sulfoximine (BSO), or by the action of the GR inhibitor, carmustine (Sakurai et al. 2004) . This indicates that a decrease in GR activity due to arsenical trivalent species makes the brain more vulnerable to the action of the less toxic arsenical pentavalent species.
The decrease in GR activity could lead to imbalance in redox status due to decrements in GSH levels in brain. Some studies have tried to correlate alterations in GSH and neurodegenerative disorders, such as Alzheimer'disease, amyotrophic lateral sclerosis, schizophrenia and Parkinson's disease (Bharath et al., 2002; Wullner et al., 1996) .
Loss of glutathione and consequent oxidative damage has been suggested to be early signaling events in apoptotic cell death. A decrease in GSH triggers the activation of neuronal 12-lipoxygenase, which leads to the production of peroxides, influx of calcium and ultimately cell death (Schulz et al., 2000) . In this regard, arsenite exposure causes apoptosis by caspase activation in cortical cell cultures, while in cerebellar cell cultures apoptosis was induced by arsenite or DMA, the former being more toxic Xia, 2000, 2001) . Choline, folate, B6 and B12 metabolism interact at the point where homocysteine is converted to methionine, which is the substrate of methionine adenosyltranferase to produce SAM (Niculescu and Zeisel, 2002) , the most important methyl donor on arsenical biomethylation process ( Figure 5 ). Biomethylation of arsenic is considered in most mammal species the major route for arsenic biotransformation and elimination (Tice et al., 1997) . Animal models of methionine, choline and folate deficiency reported alterated methylation and elimination of arsenic (Marafante and Vather, 1986; Vather and Marafante, 1987; Tice et al., 1997; Spielgestein et al., 2003) . Our results showed that important arsenic biomethylation activity occurs in mice brain, which might be impaired by nutritional deficiencies. On the other hand, the toxic effects of arsenic in the nervous system could be attributed not only to the direct action of the more toxic trivalent arsenicals on enzymes (Styblo and Thomas, 1995; Styblo et al.,1997; Chouchane and Snow, 2001) , oxidative stress (García-Chavez et al., 2003) , decrease in GR activity (present study) but also to biotransformation of arsenic. Arsenical biotransformation might alter the homeostasis of SAM, and its intermediate metabolites such as methionine, choline, folate, vitamins B6 and B12, some of them important substrates or cofactors in neurotransmitter metabolism (acetylcholine, monoamines, amino acids) (Zeizel and Blusztajn, 1994; Bottiglieri et al., 2000; Meck and Williams, 2003) or in the development of the central nervous system (Rodriguez et al., 2002) , especially in genetically susceptible organisms (Wlodarczyk et al., 2001) . In this respect, one clinical case report described a 16-year-old girl with mental deterioration, parapesia, areflexia and bilateral Babinsky signs caused by exposure to copper acetate arsenite. Laboratory blood tests reported hyperhomocysteinemia caused by deficiency of 5,10-methylene-tetrahydrofolate reductase (MTHFR), enzyme that converts 5,10 methylene tetrahydrofolate to 5-methyltetrahydrofolate (Brouwer et al. It is well known that plasma homocysteine concentration is modulated by nutritional status for folate, vitamin B6, and vitamin B12 (Cuskelly et al., 2001 ).
Findings from this study support the notion that arsenic is an environmental toxin that can affect central nervous system through several pathways. Arsenic enters, accumulates and undergoes biomethylation in brain. Arsenicals neurotoxicity could be due Values represent mean ± standard deviation. 
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